Tenet Healthcare CORP Form 4 insider transactions

Lisa Y. Foo, Executive Vice President and Chief Operating Officer of Tenet Healthcare Corp, sold 8,000 shares of common stock for a weighted average price of $179.53 per share under a Rule 10b5-1 trading plan.

A Tenet Healthcare Corp. director sold 3,952 shares of common stock for $176.39 per share, reducing their beneficial ownership to 12,358 shares.

Tenet Healthcare Corp's EVP & CFO, Sun Park, acquired 20,707 common shares through RSU vesting, with 8,813 shares withheld for tax obligations.

Tenet Healthcare's CEO, Saumya Sutaria, was granted 106,682 shares of common stock after the company's Human Resources Committee certified the achievement of performance targets.

Richard W. Fisher, a Director at Tenet Healthcare Corp, reported the sale of 836 shares of common stock for approximately $144,600.

Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare Corp., reported the sale of 7,738 shares of common stock for approximately $1.34 million.

A director at Tenet Healthcare Corp. has sold 4,613 shares of common stock for $170 per share, reducing their direct beneficial ownership to 35,271 shares, as part of a pre-arranged 10b5-1 trading plan.

J. Robert Kerrey, a Director at Tenet Healthcare Corp, reported the sale of 1,222 shares of common stock for approximately $201,500.

Tenet Healthcare Corp. Director James L. Bierman sold 1,551 shares of common stock for approximately $165.72 per share on May 27, 2025, as part of a pre-arranged 10b5-1 trading plan.

Richard W. Fisher, a Director at Tenet Healthcare Corp., reported the sale of 3,077 shares of common stock at a price of $165.72 per share on May 27, 2025.

Tenet Healthcare Corp. Director James L. Bierman sold 13,836 shares of common stock for approximately $2.2 million after exercising restricted stock units, while also receiving a new RSU grant.

Tenet Healthcare Corp. Director Cecil D. Haney reported the exercise of restricted stock units, a subsequent sale of common stock, and the grant of new restricted stock units, as detailed in a recent SEC Form 4 filing.

Tenet Healthcare Corp. Director Richard W. Fisher reported the settlement of restricted stock units, the sale of common stock, and the grant of new restricted stock units.

Tenet Healthcare Corp. Director Roy Blunt reported the conversion of restricted stock units into common stock and the grant of new restricted stock units, aligning with standard compensation practices.

Tenet Healthcare Director Nadja West reported the settlement of restricted stock units, the sale of common stock, and the grant of new restricted stock units in recent transactions.

A Tenet Healthcare Corp director reported acquiring common stock through the exercise of restricted stock units and receiving a new grant of restricted stock units.

Tenet Healthcare Corp. Director Tammy Romo reported the acquisition of common stock through RSU settlement, a subsequent sale of shares, and the grant of new restricted stock units.

Tenet Healthcare Corp. Director Christopher S. Lynch increased his direct beneficial ownership of common stock to 16,310 shares following the conversion of 1,551 restricted stock units and the grant of an additional 1,333 restricted stock units.

Tenet Healthcare Corp. Director Richard J. Mark reported recent stock transactions, including the acquisition of shares from RSU settlement, a subsequent sale of common stock, and a new grant of restricted stock units.

Tenet Healthcare Corp. Director Meghan Fitzgerald reported the vesting of restricted stock units and the subsequent sale of a portion of the resulting common stock, alongside a new RSU grant.

Tenet Healthcare Corp. Director J. Robert Kerrey reported exercising restricted stock units and subsequently selling a portion of common stock, while also receiving a new grant of restricted stock units.

Tenet Healthcare Corp. Director Vineeta Agarwala reported the grant of 1,333 restricted stock units and the exercise and subsequent disposition of 1,551 restricted stock units into common stock.

Thomas W. Arnst, EVP, Chief Administrative Officer & General Counsel of Tenet Healthcare Corporation, reported the sale of 9,786 shares of common stock at $166 per share, executed under a Rule 10b5-1 trading plan.

Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare Corp, sold 6,461 shares of common stock on May 15, 2025.

Director J. Robert Kerrey of Tenet Healthcare Corp. (THC) recently sold shares of the company's common stock in multiple transactions.

Director J. Robert Kerrey of Tenet Healthcare Corp. (THC) sold a portion of his holdings in a series of transactions on March 11, 2025.

EVP, Chief Admin. Officer & GC of Tenet Healthcare, Thomas W. Arnst, reports gifting 16,000 shares of common stock.

Director Cecil D. Haney sold 2,500 shares of Tenet Healthcare Corp (THC) at $124.26 on March 4, 2025, leaving him with 12,035 shares.

Lisa Foo, EVP of Commercial Operations at Tenet Healthcare, reports the vesting and conversion of restricted stock units into common stock, along with a tax withholding transaction.

CEO Saumya Sutaria reports acquisition and disposal of Tenet Healthcare stock and derivative securities related to vesting of restricted stock units.